Mineralocorticoid-R Control of HPA Stress Response
盐皮质激素-R 对 HPA 应激反应的控制
基本信息
- 批准号:6528776
- 负责人:
- 金额:$ 2.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-02 至
- 项目状态:未结题
- 来源:
- 关键词:adrenalectomy adrenocorticotropic hormone biofeedback corticosteroid receptors corticotropin releasing factor depression disease /disorder model gene expression hippocampus hormone regulation /control mechanism hypothalamic pituitary adrenal axis immunocytochemistry in situ hybridization laboratory rat neuroendocrine system neuroregulation posttraumatic stress disorder protein protein interaction protein structure function radioimmunoassay stress tissue /cell culture western blottings
项目摘要
DESCRIPTION (provided by applicant): The proposed research will explore the
potential role of the mineralocorticoid receptor (MR) in the regulation of the
hypothalamic-pituitary-adrenal axis (HPA) under conditions of stress. The HPA
secretes increased cortisol or corticosterone (CORT) when an organism is
confronted by stress, while secreting a low level of CORT during non-stress
states. To prevent excessive activity of the axis, CORT negative feedback
limits the operation of this hormone system. Negative feedback is mediated by
two receptors for CORT: the glucocorticoid receptor (GR) and MR. Traditionally,
GR is thought to control the HPA during a stress response and MR thought to
control the HPA in non-stress, basal states. However, the role of MR might also
be to regulate the HPA in stress situations. The role of MR may be especially
important during milder stress. such as the challenges people face every day.
If MR are not functioning properly because of experiential or congenital
effects, an organism may show an increased HPA response to stress. Abnormal HPA
function has been connected with depression, PTSD, and other psychopathologies.
It is therefore relevant to better understand the role of MR in HPA control. To
accomplish this, a range of stressor will be identified in which the HPA
requires MR for normal control of the CORT response. This will be accomplished
via treatment of animals with MR antagonists (e.g., RU28318), and then
observing their CORT, ACTH, and CRH response to stress. Then, the interaction
between MR and GR control of the HPA will be examined in several stressors of
varying intensities. This will be done to better understand the exact nature of
MR contribution to control of the HPA during stress. And finally, the role of
MR in controlling HPA responding will be examined after a stressor has been
experienced repeatedly, a situation previously shown to increase the number of
brain MR.
描述(由申请人提供):拟议的研究将探索
盐皮质激素受体(MR)在调节中的潜在作用
压力条件下的下丘脑-垂体-肾上腺轴(HPA)。健康促进协会
当有机体处于
面临压力时,在非压力时分泌低水平的 CORT
州。为了防止轴过度活动,CORT 负反馈
限制了这种激素系统的运作。负反馈的调节是通过
CORT 有两种受体:糖皮质激素受体 (GR) 和 MR。传统上,
GR 被认为可以在应激反应期间控制 HPA,而 MR 则被认为可以控制 HPA。
将 HPA 控制在无压力的基础状态。然而,MR 的作用也可能是
是在压力情况下调节 HPA。 MR 的作用可能尤其重要
在轻度压力下很重要。例如人们每天面临的挑战。
如果 MR 由于经验性或先天性而无法正常运作
效应,生物体可能表现出对压力的 HPA 反应增强。异常HPA
功能与抑郁症、创伤后应激障碍和其他精神病理学有关。
因此,更好地了解 MR 在 HPA 控制中的作用非常重要。到
要实现这一目标,将确定一系列压力源,其中 HPA
需要 MR 来正常控制 CORT 反应。这将实现
通过用 MR 拮抗剂(例如 RU28318)治疗动物,然后
观察他们对压力的 CORT、ACTH 和 CRH 反应。然后,互动
MR 和 GR 对 HPA 的控制之间的关系将在以下几个压力源中进行检查
不同的强度。这样做是为了更好地理解的确切性质
MR 对压力期间 HPA 控制的贡献。最后,角色
压力源消除后,将检查控制 HPA 反应的 MR
反复经历过,以前表明这种情况会增加数量
大脑先生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THADDEUS PACE其他文献
THADDEUS PACE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THADDEUS PACE', 18)}}的其他基金
Reducing Psychological Distress in Fire Fighters with an Asynchronous App-based Meditation Intervention
通过基于应用程序的异步冥想干预减少消防员的心理困扰
- 批准号:
10590943 - 财政年份:2023
- 资助金额:
$ 2.52万 - 项目类别:
Leveraging social connection by including informal caregivers in an internet video conference-based compassion meditation intervention to reduce psychological distress in breast cancer survivors
通过让非正式护理人员参与基于互联网视频会议的同情冥想干预,利用社会联系来减少乳腺癌幸存者的心理困扰
- 批准号:
10518639 - 财政年份:2022
- 资助金额:
$ 2.52万 - 项目类别:
Leveraging social connection by including informal caregivers in an internet video conference-based compassion meditation intervention to reduce psychological distress in breast cancer survivors
通过让非正式护理人员参与基于互联网视频会议的同情冥想干预来利用社会联系,以减少乳腺癌幸存者的心理困扰
- 批准号:
10661837 - 财政年份:2022
- 资助金额:
$ 2.52万 - 项目类别:
Stress Inflammation Mechanisms of Survivorship Disparities Experienced by Hispanic Women After Breast Cancer
西班牙裔女性乳腺癌后生存差异的应激炎症机制
- 批准号:
9296607 - 财政年份:2017
- 资助金额:
$ 2.52万 - 项目类别:
Meriva for treatment-induced inflammation and fatigue in women with breast cancer
Meriva 治疗乳腺癌女性治疗引起的炎症和疲劳
- 批准号:
8755360 - 财政年份:2014
- 资助金额:
$ 2.52万 - 项目类别:
Meriva for treatment-induced inflammation and fatigue in women with breast cancer
Meriva 治疗乳腺癌女性治疗引起的炎症和疲劳
- 批准号:
8927561 - 财政年份:2014
- 资助金额:
$ 2.52万 - 项目类别:
Development of a novel NF-kB antagonist to block cytokine-induced behavioral chan
开发新型 NF-kB 拮抗剂来阻断细胞因子诱导的行为变化
- 批准号:
7916801 - 财政年份:2009
- 资助金额:
$ 2.52万 - 项目类别:
Development of a novel NF-kB antagonist to block cytokine-induced behavioral chan
开发新型 NF-kB 拮抗剂来阻断细胞因子诱导的行为变化
- 批准号:
7740066 - 财政年份:2009
- 资助金额:
$ 2.52万 - 项目类别:
Inflammation & glucocorticoid signaling in early life stress and major depression
炎
- 批准号:
7541711 - 财政年份:2007
- 资助金额:
$ 2.52万 - 项目类别:
Mineralocorticoid-R Control of HPA Stress Response
盐皮质激素-R 对 HPA 应激反应的控制
- 批准号:
6607186 - 财政年份:2002
- 资助金额:
$ 2.52万 - 项目类别:
相似国自然基金
下丘脑室旁核促肾上腺皮质激素释放激素神经元调控奖赏偏好行为的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
孕期促肾上腺皮质激素释放激素(CRH)通过引起DNA甲基化发生程序化稳定改变长期影响婴幼儿神经行为发育
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:
INSM1在静默性促肾上腺皮质激素细胞腺瘤发生发展中的调控机制及潜在靶向治疗研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
促肾上腺皮质激素释放因子通过CRFR1-cAMP-SphK1通路介导肥大细胞脱颗粒参与胰腺癌痛外周敏化
- 批准号:82171232
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
催产素参与双相障碍发病机制的研究:聚焦于促肾上腺皮质激素释放激素与催产素之间的平衡紊乱
- 批准号:81971268
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Regulation of adrenocorticotropic hormone secretion from the anterior pituitary gland
垂体前叶促肾上腺皮质激素分泌的调节
- 批准号:
RGPIN-2018-04676 - 财政年份:2021
- 资助金额:
$ 2.52万 - 项目类别:
Discovery Grants Program - Individual
Regulation of adrenocorticotropic hormone secretion from the anterior pituitary gland
垂体前叶促肾上腺皮质激素分泌的调节
- 批准号:
RGPIN-2018-04676 - 财政年份:2020
- 资助金额:
$ 2.52万 - 项目类别:
Discovery Grants Program - Individual
Regulation of adrenocorticotropic hormone (ACTH) secretion
促肾上腺皮质激素 (ACTH) 分泌的调节
- 批准号:
540880-2019 - 财政年份:2019
- 资助金额:
$ 2.52万 - 项目类别:
University Undergraduate Student Research Awards
Regulation of adrenocorticotropic hormone secretion from the anterior pituitary gland
垂体前叶促肾上腺皮质激素分泌的调节
- 批准号:
RGPIN-2018-04676 - 财政年份:2019
- 资助金额:
$ 2.52万 - 项目类别:
Discovery Grants Program - Individual
Regulation of adrenocorticotropic hormone secretion from the anterior pituitary gland
垂体前叶促肾上腺皮质激素分泌的调节
- 批准号:
RGPIN-2018-04676 - 财政年份:2018
- 资助金额:
$ 2.52万 - 项目类别:
Discovery Grants Program - Individual